{"id":"W3013689722","doi":"10.1093/eurheartj/ehaa183","title":"Effects of dapagliflozin in DAPA-HF according to background heart failure therapy","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Montreal Heart Institute; St. Michael's Hospital; Université de Montréal; University of Calgary","funders":"Janssen Research and Development; Relypsa; Respicardia; American Regent; Vifor Pharma; University of Glasgow; University of Oxford; GlaxoSmithKline; IFM Therapeutics; Zora Biosciences; Medicines Company; Intarcia Therapeutics; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Sanofi Pasteur; Celladon Corporation; Boston Scientific Corporation; Esperion Therapeutics; Alnylam Pharmaceuticals; Novo Nordisk; MyoKardia; Daiichi Sankyo Europe; Servier; Gilead Sciences; British Heart Foundation; Eisai; Cytokinetics; Brigham and Women's Hospital; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Dapagliflozin; Heart failure; Internal medicine; Cardiology; Intensive care medicine; Diabetes mellitus; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004023126,0.000162986,0.0003712013,0.0001678327,0.00005355588,0.00005618646,0.0001132289,0.0000199608,0.0001038207],"category_scores_gemma":[0.00007108597,0.0001316334,0.0001395037,0.0003144564,0.00001670148,0.0001271304,0.00008105591,0.0002763233,0.0002799091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004769741,"about_ca_system_score_gemma":0.00002984312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002702478,"about_ca_topic_score_gemma":0.000001001416,"domain_scores_codex":[0.9987155,0.0002143373,0.000297704,0.0002069958,0.0002690455,0.0002964453],"domain_scores_gemma":[0.9993391,0.00007148679,0.00006323367,0.0001435156,0.000040127,0.0003425466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001049985,0.0009782339,0.4202841,0.0004472762,0.000555165,0.001733086,0.002837881,0.00009402854,0.3245696,0.0001911498,0.2206879,0.02657155],"study_design_scores_gemma":[0.007732936,0.003596434,0.4869755,0.0007654392,0.00009960723,0.0001016921,0.0008912447,0.00004592236,0.0217397,0.00001340904,0.477755,0.0002830645],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827754,0.0005775262,0.00009856468,0.0129058,0.000163207,0.0004686049,7.217682e-7,0.00003452184,0.002975605],"genre_scores_gemma":[0.9894612,0.00008513543,0.002938911,0.006734106,0.0005191757,0.000002849044,0.000002232842,0.00004571779,0.0002106516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3028299,"threshold_uncertainty_score":0.5367853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04614080568063384,"score_gpt":0.2951279098401081,"score_spread":0.2489871041594742,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}